Chronic kidney disease and t ype 2 diabetes Chronic kidney disease and t ype 2 diabetes To reduce the risk of worsening kidney disease and cardiovascular death in patients with type 2 diabetes, initiate treatment on the 0.25 mg injection dosage for 4 weeks, then increase to 0.5 mg once weekly after 4 weeks on the lower 0.25 mg dose
They will not eliminate nausea, but they can take the edge off
Jensterle et al., 2021), including 4,521 individuals, mentioned relative body weight (RBW) and absolute body weight (ABW) changes, five of which were dosed at 2.4 mg/week, one at 1.0 mg/week, and the other by dose escalation
Whelton PK (2018): 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines